catherine sautes-fridman

Emeritus Professor

Université Paris Descartes

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

ORCID

Google Scholar

About

Catherine Sautes-Fridman is an Emeritus Professor at Université Paris Descartes in France. Her research primarily focuses on cancer immunity, specifically the roles of B cells and the tumor microenvironment in various types of cancers. Recent articles authored by her explore the interplay between anti-tumor immune responses and autoimmunity, as well as implications for immunotherapy in renal cell carcinoma and melanoma.

catherine sautes-fridman

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

High Circulating IL-6/IL-8 Is Associated with Intratumoral Myeloid Contexture and Poor Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade

B cells are major players in cancer immunity

Unraveling the complex interplay between anti-tumor immune response and autoimmunity mediated by B cells and autoantibodies in the era of anti-checkpoint monoclonal antibody therapies.

Timing and location dictate monocyte fate and their transition to tumor-associated macrophages

B cells! Don’t go the wrong way in this tumor

Impact of metronomic trabectedin combined with low-dose cyclophosphamide on sarcoma microenvironment and correlation with clinical outcome: results from the TARMIC study

Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy

Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?

Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial

Silencing of genes by promoter hypermethylation shapes tumor microenvironment and resistance to immunotherapy in clear-cell renal cell carcinomas

Tertiary lymphoid structures and B cells: An intratumoral immunity cycle

Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell Carcinoma

B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome.

An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas

C1q+ macrophages: passengers or drivers of cancer progression

How molecularly similar are primary and metastatic tissues in renal cell carcinoma? – Authors’ reply

Optimal molecular selection to benefit from nivolumab–ipilimumab in clear-cell renal cell carcinoma

Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors

Les structures lymphoïdes tertiaires génèrent et propagent des plasmocytes produisant des anticorps antitumoraux dans le cancer du rein

Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort

Collaborators (11)

Sophie Siberil

Mariella Spalato Ceruso

Maxime Meylan

Patrick Dicker

Lubka T. Roumenina

Annette Byrne

Cheng-Ming Sun

Stéphane Oudard

Benoit Beuselinck

Ankur Sharma

Teresa Maria Rosaria Noviello

How do I reach out?

Meet Kite AI